BRIEF published on 01/23/2026 at 07:05, 18 days 20 hours ago BB Biotech AG Reports Significant Profit for 2025 Investment Company BB Biotech AG Drug Developers 2025 Profit Share Price Development
BRIEF published on 01/23/2026 at 07:05, 18 days 20 hours ago BB Biotech AG annonce des bénéfices importants pour 2025 BB Biotech AG Société D'investissement Développeurs De Médicaments Bénéfices 2025 Évolution Du Cours De L'action
BRIEF published on 01/23/2026 at 07:05, 18 days 20 hours ago BB Biotech annonce des résultats préliminaires solides pour 2025 et une proposition de dividende Proposition De Dividende BB Biotech Performance Des Actions Résultats Financiers 2025 Investissement En Biotechnologie
BRIEF published on 01/23/2026 at 07:05, 18 days 20 hours ago BB Biotech Reports Strong Preliminary 2025 Results and Dividend Proposal Dividend Proposal Share Performance BB Biotech Biotech Investment 2025 Financial Results
PRESS RELEASE published on 01/23/2026 at 07:00, 18 days 20 hours ago EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit BB Biotech AG closes the 2025 fiscal year with a profit of approximately CHF 578 million, reflecting share price development. Full report on Feb 20, 2026 BB Biotech AG Profit 2025 Fiscal Year Share Price Development CHF 578 Million
PRESS RELEASE published on 01/23/2026 at 07:00, 18 days 20 hours ago BB Biotech: Preliminary full-year 2025 results and dividend proposal BB Biotech AG reports strong full-year 2025 results with +34.2% total return in CHF, +37.0% in EUR, and +53.7% in USD, proposes dividend of CHF 2.25 per share at AGM on March 19, 2026 Dividend Proposal Stock Market Full-year Results BB Biotech AG 2025 Performance
BRIEF published on 10/28/2025 at 13:20, 3 months 13 days ago BB Biotech Outperforms with Strong Q3 2025 Results Biotech Sector M&A BB Biotech Q3 2025 Nasdaq Biotech Index
BRIEF published on 10/28/2025 at 13:20, 3 months 13 days ago BB Biotech surperforme avec de solides résultats au troisième trimestre 2025 Fusions Et Acquisitions BB Biotech T3 2025 Secteur Des Biotechnologies Indice NASDAQ Biotech
PRESS RELEASE published on 10/28/2025 at 13:15, 3 months 13 days ago Edison issues report on BB Biotech (BION) Edison issues positive report on BB Biotech (BION) with strong Q325 results, outperforming its benchmark. Sector outlook remains favorable with M&A as key performance driver Edison M&A BB Biotech Outperforming Q325 Results
BRIEF published on 10/24/2025 at 07:05, 3 months 17 days ago BB Biotech AG Releases Interim Report Highlighting Significant Profit Increase Investment Company BB Biotech AG Interim Report Net Profit Increase Drug Developers
Published on 02/11/2026 at 03:05, 33 minutes ago CANEX Metals Announces Final Take Up of Gold Basin Shares and Expiry of Successful Gold Basin Offer
Published on 02/11/2026 at 01:00, 2 hours 38 minutes ago Kidoz Inc. Appoints John Nolie as Vice President of Sales, North America
Published on 02/10/2026 at 22:50, 4 hours 48 minutes ago Tectonic Metals Announces Financing of up to $40 Million
Published on 02/10/2026 at 22:15, 5 hours 23 minutes ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/10/2026 at 15:30, 12 hours 8 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/11/2026 at 02:30, 1 hour 8 minutes ago CGTN: Little Chinese New Year opens big window to China's soul
Published on 02/10/2026 at 23:33, 4 hours 4 minutes ago EQS-Adhoc: All for One Group SE: resolves on a public share buyback offer for up to 2.3% of the share capital and proposes to the Annual General Meeting an amended appropriation of retained earnings
Published on 02/10/2026 at 22:51, 4 hours 47 minutes ago Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 22:28, 5 hours 9 minutes ago EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 19:07, 8 hours 31 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 18:24, 9 hours 13 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 9 hours 13 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 9 hours 38 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 9 hours 38 minutes ago CIS wins several strategic contracts in Africa, South America and Asia
